Overview

Technology and Heart Failure Therapeutics (THT) 2026 is a three-day, in-person heart failure conference taking place from 2–4 March 2026 at the Omni Boston Hotel at the Seaport, Boston, MA, United States. The meeting is aimed at interventional cardiologists, heart failure specialists, electrophysiologists, structural heart specialists and the wider heart team managing complex heart failure and cardiogenic shock. It focuses on device therapy, mechanical circulatory support, cardiogenic shock pathways, advanced haemodynamics and structural interventions in heart failure.

Who should attend

• Interventional cardiologists and heart failure specialists involved in advanced device therapy, LVAD and MCS.
• Electrophysiologists and structural heart specialists treating heart failure patients with CRT, ICD and mitral/tricuspid interventions.

Programme highlights

• Late-breaking clinical trials in heart failure interventions, device therapy and mechanical circulatory support.
• Case-based and “how-to” sessions on cardiogenic shock management, invasive haemodynamics, LVAD optimisation and structural interventions in heart failure.
• Content on remote monitoring, digital health and AI-enabled heart failure pathways.

Practical information

• Dates: 2–4 March 2026
• Location: Omni Boston Hotel at the Seaport, Boston, MA, United States